Digital application for the diagnosis and treatment of Alzheimer's disease
Samsung has collaborated with medtech start-up Bottneuro to advance the digital diagnosis and treatment of Alzheimer's disease. Together, the companies aim to bring the ability to diagnose and treat the disease to people's homes. The start-up uses the Samsung Galaxy Tab S8+ Enterprise Edition to record and store the therapy data of Alzheimer's patients.
New therapeutic approaches thanks to advanced technologyThe start-up wants to stop the progression of Alzheimer's disease. To do so, it uses an approach that uses 3D MRI (Magnetic Resonance Imaging) and PET (Positron Emmision Tomography) data to identify areas of the brain that are particularly affected by the disease. Exactly these brain areas are then electrically stimulated with a personalised and 3D-printed Miamind® neurostimulator. The tablet will then be able to simplify the therapy through a graphical interface.
In addition, it supplies the neurostimulator directly with electricity during the treatment. All recorded diagnostic and treatment data are automatically transmitted to the start-up. Thus, patients should hardly have any additional effort during treatment in their own homes.
The effectiveness of the therapeutic treatment will be tested in several clinical studies before the end of this year.